Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Surgery in ulcerative colitis: When? How?

Academic Article
Publication Date:
2018
Short description:
Surgery in ulcerative colitis: When? How? / Gallo, G., Kotze, P.G., Spinelli, A.. - In: BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL GASTROENTEROLOGY. - ISSN 1521-6918. - 32-33:February–April 2018(2018), pp. 71-78. [10.1016/j.bpg.2018.05.017]
abstract:
Ulcerative Colitis (UC) is an idiopathic chronically-remitting inflammatory bowel disorder characterized by a contiguous inflammation of the colonic mucosa affecting the rectum that generally extends proximally in a continuous manner through the entire colon. Patients typically experience intermittent exacerbations, with symptoms characterized by bloody diarrhea associated with urgency and tenesmus. The anatomical extent of mucosal involvement is the most important factor determining disease course and is an important predictor of colectomy. The precise etiology of UC is unknown. However, a combination of genetic predisposition and environmental factors seems to have a key role in the development of the disease. UC usually is mildly active but it can be a life-threatening condition because of colonic and systemic complications, and later in the disease course due to the development of colorectal cancer. Interestingly, even if pathogenetic features detected in patients with sporadic CRC can be also found in UC-related colorectal cancer (UC-CRC), this latter is, usually, driven by an inflammation-driven pathway rising from a non-neoplastic inflammatory epithelium to dysplasia to cancer. Thus, a long-term follow-up with colonoscopy surveillance has been recommended. Approximately 15% of UC patients develop an acute attack of severe colitis, and 30% of these patients require colectomy. The initial treatment strategy in UC typically follows the traditional step-up approach. One third of the patients will not respond to steroid therapy and cyclosporine and infliximab are the most common salvage agents employed in these cases in order to avoid emergent surgery. Unfortunately, although a significant short-term benefit have been observed after infliximab treatment, the colectomy rate have remained stable. Surgery in UC depends on the stage of the disease as well as patient's status and is divided into the following settings: urgent, emergent and elective. Despite many efforts the surgical management of UC remains a significant challenge. A multidisciplinary management of UC is key in order to define the best timing and the best procedure for each patient in an individualized basis.
Iris type:
1.1 Articolo in rivista
Keywords:
inflammatory bowel disease; medications; multidisciplinary management; surgery; timing; ulcerative colitis
List of contributors:
Gallo, G.; Kotze, P. G.; Spinelli, A.
Authors of the University:
GALLO GAETANO
Handle:
https://iris.unisr.it/handle/20.500.11768/188893
Published in:
BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL GASTROENTEROLOGY
Journal
  • Overview

Overview

URL

https://www.sciencedirect.com/science/article/pii/S1521691818300283
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.9.0.0